The Galleri® Cancer Test is a comprehensive blood test designed for early detection of multiple types of cancer. Using advanced genomic analysis, it identifies abnormalities in methylation patterns of cell-free DNA, which could indicate the presence of more than 50 types of cancer, including breast, lung, colon, prostate, and pancreatic cancers. This test is validated by rigorous clinical studies and is intended to be used alongside guideline-recommended screenings to improve early detection and outcomes. While not all cancers can be detected through this method, the Galleri test is a valuable tool for enhancing your cancer screening regimen.
